Carlos M. Villalón - Concepedia

Author

Carlos M. Villalón

Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional ORCID

Also Known As

C M Villalón, C VILLALON, C Villalón, C. M. VILLALON, C. M. VILLALÓN, C. M. Villalon, C. M. Villalón, C. Villalon, C.M. Villalón, CM Villalón

214

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional Erasmus University Rotterdam Erasmus MC Universidad Nacional Autónoma de México Instituto Politécnico Nacional

About

Carlos M. Villalón is an author at Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional specializing in physiology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	64	1.7K
2	Health Sciences	11	13	300
3	Social Sciences	8	8	225
4	Public Health	2	2	106
5	Natural Sciences	1	1	15

Carlos M. Villalón

100

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Mediation of 5‐hydroxytryptamine‐induced tachycardia in the pig by the putative 5‐HT<sub>4</sub> receptor Carlos M. Villalón, Marien O. den Boer, Jan P.C. Heiligers, British Journal of Pharmacology	1990	120
5-HT 1 -like receptors: a time to bid goodbye P. R. Saxena, Peter de Vries, Carlos M. Villalón Trends in Pharmacological Sciences Signal TransductionFunctional SelectivityMedicineReceptor (Biochemistry)Neuropharmacology	1998	93
Cardiovascular effects of serotonin agonists and antagonists. Carlos M. Villalón PubMed	1990	91
Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system Alejandro Labastida‐Ramírez, Eloísa Rubio‐Beltrán, Kristian Agmund Haanes, Pain	2020	89
Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery Kayi Y. Chan, Michael Baun, René de Vries, Cephalalgia	2010	82
Characterization of binding, functional activity, and contractile responses of the selective 5‐HT<sub>1F</sub> receptor agonist lasmiditan Eloísa Rubio‐Beltrán, Alejandro Labastida‐Ramírez, Kristian Agmund Haanes, British Journal of Pharmacology	2019	71
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5‐HT<sub>1B/1D</sub> receptors and <i>α</i><sub>2</sub>‐adrenoceptors Carlos M. Villalón, Peter de Vries, Gonzalo Rabelo, British Journal of Pharmacology	1999	69
Mediation of 5‐HT‐induced external carotid vasodilatation in GR 127935‐pretreated vagosympathectomized dogs by the putative 5‐HT<sub>7</sub> receptor Carlos M. Villalón, David Centurión, Miguel Luján‐Estrada, British Journal of Pharmacology	1997	68
Characterisation of CGRP receptors in human and porcine isolated coronary arteries: Evidence for CGRP receptor heterogeneity Saurabh Gupta, Suneet Mehrotra, Carlos M. Villalón, European Journal of Pharmacology Coronary ArteriesVascular DiseaseMolecular PhysiologyCardiovascular DiseaseMedicine	2005	64
Possible role of Ca2+ channels in the vasodilating effect of 5β-dihydrotestosterone in rat aorta Mercedes Perusquı́a, Carlos M. Villalón European Journal of Pharmacology Signal TransductionMolecular PhysiologySodium HomeostasisMedicineVascular Pharmacology	1999	60

Page 1